NLS Pharmaceutics Ltd. Gains 23.21%

NLS Pharmaceutics Ltd. (NLSP:NASDAQ) shot up at $0.66, representing a gain of 23.2%. On Tue, Aug 23, 2022, NLSP:NASDAQ hit a New 2-Week High of $0.66. The stock got featured on our News Catalysts scanner on Thu, Jul 28, 2022 at 09:29 AM in the 'PRIVATE PLACEMENT' category. From Tue, Aug 09, 2022, the stock recorded 70.00% Up Days and 45.45% Green Days
The stock spiked on Mon, Aug 22, 2022 at $0.77 with a volume of 3M+.
About NLS Pharmaceutics Ltd. (NLSP:NASDAQ)
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders.
Top 10 Gainers:
- Reviva Pharmaceuticals Holdings Inc. (RVPH:NASDAQ), 53.04%
- Neptune Wellness Solutions Inc. (NEPT:NASDAQ), 53%
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 49.35%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- China Index Holdings Limited (CIH:NASDAQ), 42.86%
- Aerie Pharmaceuticals, Inc. (AERI:NASDAQ), 35.96%
- Nerdy Inc. Class A (NRDY:NYSE), 23.9%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 23.21%
- Secoo Holding Limited (SECO:NASDAQ), 23%
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 21.51%